Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuganlin Oral Liquid for pediatric acute upper respiratory tract infection
ChiCTR-TRC-13003322Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jul 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Fuganlin Oral Liquid in upper respiratory infection (URI) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Duration of cold. Started Jul 2013; status: completed.
02
Drugs
Fuganlin Oral Liquid
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR-TRC-13003322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003322.